Premium
Public Health Consequences of Chronic Kidney Disease
Author(s) -
Weiner DE
Publication year - 2009
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2009.137
Subject(s) - kidney disease , medicine , public health , disease , diabetes mellitus , incidence (geometry) , obesity , clinical pharmacology , population , intensive care medicine , gerontology , environmental health , pathology , endocrinology , pharmacology , physics , optics
With its rising incidence and prevalence, chronic kidney disease (CKD) is a major public health concern, both in the United States and worldwide. Recent worldwide initiatives have attempted to garner attention for CKD by emphasizing that the condition is “common, harmful, and treatable.” 1 In the United States, as many as 26 million adults may have CKD, an increase from ~10% of the US adult population between 1988 and 1994 to >13% just one decade later. 2 , 3 Similar rates have been seen worldwide, with a CKD prevalence of 13% in Beijing, China 4 and 16% in Australia. 5 In the United States, the dramatic rise in the prevalence of CKD likely reflects similar increases in obesity and its sequelae—namely, diabetes, hypertension, and cardiovascular disease. 3 The prevalence of CKD, as well as its associated costs, is expected to continue to increase. 6 Clinical Pharmacology & Therapeutics (2009) 86 5, 566–569. doi: 10.1038/clpt.2009.137